mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.05 |
mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.05 |
mRNA |
ML320 |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.05 |
mRNA |
masitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.05 |
mRNA |
ATRA |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.05 |
mRNA |
MLN4924 |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.06 |
mRNA |
YK 4-279 |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.06 |
mRNA |
BRD4132 |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.06 |
mRNA |
BRD-K09344309 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
0.06 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.06 |